Unified research guidelines represent ‘major step forward’ for interventional oncology

International experts have developed new research guidelines for interventional oncology that they say represent a “major step forward” for the important subspecialty.

Interventional oncology is a fast-growing facet of interventional radiology that focuses on applying treatment directly to tumors via a catheter. But current methods for collecting, analyzing and reporting study results widely vary, making it hard to compare outcomes.

With this in mind, a panel of 62 experts gathered to brainstorm recommendations for getting the field on the same page and enhancing image-guided tumor ablation research. 

The consensus statement was published on Sept. 28 in Radiology.

“The given definitions in these current guidelines will provide the necessary foundation for scientific reproducibility between interventional oncology studies as they will ensure an objective and reliable interpretation of study outcomes, allow for accurate comparisons of results and avoid misinterpretations,” said Robbert S. Puijk, MD, a radiology resident and researcher at the Onze Lieve Vrouwe Gasthuis Hospital and Amsterdam University Medical Centers in Amsterdam.

Among the many recommendations is an agreement that parameters such as overall survival and disease-free survival should be assessed per patient and not on a per tumor or procedure basis.

At the same time, criteria covering procedure-related side effects and direct costs should be addressed on a per procedure basis, the group explained.

Pujik and co-authors hope their guidance is adopted into cancer treatment, and that other medical organizations take interest in contributing their own expertise.

“Together with the help of independent biostatisticians and epidemiologists, it strengthens our methodology and indicates the importance of this project,” Pujik added in a statement. “Widespread adoption of these guidelines is another step forward in the professionalization of our field, interventional oncology.” 

Read the entire consensus statement here.

""

Matt joined Chicago’s TriMed team in 2018 covering all areas of health imaging after two years reporting on the hospital field. He holds a bachelor’s in English from UIC, and enjoys a good cup of coffee and an interesting documentary.

Around the web

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.